Dermavant Sciences, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$22.8M
Doctors Paid
13,703
Transactions
151,076
2024 Total
$6.8M
Payment Breakdown by Category
Research$8.9M (39.2%)
Consulting$3.6M (15.6%)
Food & Beverage$3.0M (13.0%)
Travel$832,583 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $8.9M | 15,234 | 39.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6.3M | 2,486 | 27.8% |
| Consulting Fee | $3.6M | 827 | 15.6% |
| Food and Beverage | $3.0M | 129,480 | 13.0% |
| Travel and Lodging | $832,583 | 2,369 | 3.7% |
| Grant | $151,050 | 1 | 0.7% |
| Education | $12,962 | 679 | 0.1% |
Payments by Type
General
$13.8M
135,842 transactions
Research
$8.9M
15,234 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| AN OPEN LABEL, LONG-TERM EXTENSION STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TAPINAROF CREAM 1% IN SUBJECTS WITH ATOPIC DERMATITIS | $4.9M | 0 | 5,240 |
| A PHASE 3 EFFICACY AND SAFETY STUDY OF TAPINAROF FOR THE TREATMENT OF MODERATE TO SEVERE ATOPIC DERMATITIS IN CHILDREN WITH ADULTS | $2.7M | 0 | 8,427 |
| A Phase 4, open-label study to investigate the efficacy and safety of VTAMA(tapinarof) cream, 1% in the treatment of plaque psoriasis in intertriginous areas | $536,093 | 0 | 771 |
| A Phase 4, open-label study to investigate the efficacy and safety of VTAMA(tapinarof) cream, 1% in the treatment of plaque psoriasis occurring in the head and neck region | $332,244 | 0 | 285 |
| DMVT-505-3004 | $174,880 | 0 | 53 |
| OPEN LABEL MAXIMAL USE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF TAPINAROF CREAM, 1% IN PEDIATRIC SUBJECTS WITH EXTENSIVE ATOPIC DERMATITIS | $67,052 | 0 | 176 |
| A PHASE 4, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF VTAMA (TAPINAROF) CREAM, 1% IN THE TREATMENT OF PLAQUE PSORIASIS OCCURRING IN THE HEAD AND NECK REGION | $57,765 | 0 | 241 |
| 60061781-02 | $15,356 | 0 | 1 |
| A PHASE 4, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF VTAMA (TAPINAROF) CREAM, 1% IN THE TREATMENT OF PLAQUE PSORIASIS IN INTERTRIGINOUS AREAS | $14,300 | 0 | 5 |
| DMVT-505-3004-0149 | $8,948 | 0 | 1 |
| DMVT-505-3004-0299 | $5,696 | 0 | 1 |
| DMVT-505-3004-0277 | $5,306 | 0 | 1 |
| DMVT-505-3004-0138 | $5,097 | 0 | 1 |
| DMVT-505-3004-0126 | $5,000 | 0 | 1 |
| DMVT-505-3004-0324 | $4,861 | 0 | 1 |
| DMVT-505-3004-0311 | $4,690 | 0 | 1 |
| DMVT-505-3004-0116 | $4,588 | 0 | 1 |
| DMVT-505-3004-0327 | $4,184 | 0 | 1 |
| DMVT-505-3004-0113 | $3,362 | 0 | 1 |
| DMVT-505-3004-0313 | $3,346 | 0 | 1 |
| DMVT-505-3004-0122 | $3,191 | 0 | 1 |
| DMVT-505-3004-0301 | $3,016 | 0 | 1 |
| DMVT-505-3004-0314 | $2,996 | 0 | 1 |
| DMVT-505-3004-0134 | $2,908 | 0 | 1 |
| DMVT-505-3004-0310 | $2,879 | 0 | 1 |
| DMVT-505-3004-0114 | $2,812 | 0 | 1 |
| DMVT-505-3004-0283 | $2,760 | 0 | 1 |
| DMVT-505-3004-0291 | $2,700 | 0 | 1 |
| DMVT-505-3004-0303 | $2,609 | 0 | 1 |
| DMVT-505-3004-0137 | $2,482 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Brandon Kirsch, Md, MD | Dermatology | Naples, FL | $334,333 | $0 |
| Dr. George Lewitt, M.d, M.D | Dermatology | Northbrook, IL | $279,206 | $0 |
| Mr. Michael Cameron | Dermatology | New York, NY | $221,151 | $0 |
| Dr. Joshua Zeichner, Md, MD | Dermatology | New York, NY | $190,962 | $0 |
| Dr. Ahmad Amin, M.d, M.D | Dermatology | Naperville, IL | $184,241 | $0 |
| Dr. Benjamin Lockshin, Md, MD | Dermatology | Silver Spring, MD | $174,243 | $0 |
| Dr. Ein Song, M.d, M.D | Dermatology | Mill Creek, WA | $172,152 | $0 |
| Omar Noor, M.d, M.D | Student in an Organized Health Care Education/Training Program | Somerset, NJ | $168,406 | $0 |
| Dr. Alexandra Golant, M.d, M.D | Dermatology | New York, NY | $168,132 | $0 |
| Dr. Matthew Zirwas, Md, MD | Dermatology | Bexley, OH | $165,944 | $0 |
| Dr. Cory Rubin, M.d, M.D | Clinical & Laboratory Dermatological Immunology | Waterford, MI | $165,834 | $0 |
| Pranav Sheth, M. D, M. D | Dermatology | West Chester, OH | $165,168 | $0 |
| Andrea Suarez | Student in an Organized Health Care Education/Training Program | Denver, CO | $135,000 | $0 |
| Matthew Bruno, Pa C, PA C | Physician Assistant | Allen, TX | $132,368 | $0 |
| Dr. Naiem Issa, M.d., Ph.d, M.D., PH.D | Dermatology | Vienna, VA | $132,258 | $0 |
| Linda Stein Gold, M.d, M.D | Dermatology | West Bloomfield, MI | $124,466 | $0 |
| Dr. Russell Cohen, M.d, M.D | Dermatology | Oceanside, NY | $123,559 | $0 |
| Ms. Stephanie Simmerman, Arnp, ARNP | Nurse Practitioner | Naples, FL | $121,401 | $0 |
| Holly Glover, Pa-C, PA-C | Medical | Dallas, TX | $107,449 | $0 |
| Dr. Anthony Nuara, M.d., Ph.d, M.D., PH.D | Dermatology | Scottsdale, AZ | $106,262 | $0 |
| Rocco Serrao, Md, MD | Dermatology | Dayton, OH | $99,207 | $0 |
| Dr. Renee Sheinin, M.d, M.D | Dermatology | Sherman Oaks, CA | $98,973 | $0 |
| Mona Shahriari | Dermatology | Cromwell, CT | $98,866 | $0 |
| Dr. Andrew Lee, M.d, M.D | Dermatology | Elkin, NC | $97,388 | $0 |
| Adelaide Hebert, M.d, M.D | Pediatric Dermatology | Bellaire, TX | $95,941 | $0 |
About Dermavant Sciences, Inc.
Dermavant Sciences, Inc. has made $22.8M in payments to 13,703 healthcare providers, recorded across 151,076 transactions in the CMS Open Payments database. In 2024, the company paid $6.8M. The top product by payment volume is VTAMA ($21.3M).
Payments were distributed across 131 medical specialties. The top specialty by payment amount is Dermatology ($8.2M to 5,003 doctors).
Payment categories include: Food & Beverage ($3.0M), Consulting ($3.6M), Research ($8.9M), Travel & Lodging ($832,583).
Dermavant Sciences, Inc. is associated with 2 products in the CMS Open Payments database.